, 百拇医药
关键词:扶正化瘀方;巨噬细胞;一氧化氮;一氧化氮合酶;MAPK信号通路;JNK信号通路
中图分类号:R285.5 文献标识码:A 文章编号:1005-5304(2020)03-0043-05
DOI:10.3969/j.issn.1005-5304.201909314
Effects of Fuzheng Huayu Prescription on LPS-induced Inflammatory M1 Polarization of RAW264.7 Macrophages Through JNK Pathway
ZHANG Man1, HU Xudong2, HUANG Kai1, TAO Yanyan1, PENG Yuan1, LIU Chenghai1,3,4
, 百拇医药
1. Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; 2. School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; 3. Key Laboratory of Liver and Kidney Diseases of Shanghai University of Traditional Chinese Medicine, Ministry of Education, Shanghai 201203, China; 4. Shanghai Key Laboratory of Clinical Chinese Medicine, Shanghai 201203, China
, 百拇医药
Abstract: Objective To explore the effects of Fuzheng Huayu Prescription on iNOS gene overexpression and NO overproduction in M1 polarized RAW264.7 macrophages induced by lipopolysaccharide (LPS); To discuss its possible anti-inflammatory mechanism. Methods LPS was used to stimulate mouse RAW264.7 macrophages to establish an inflammatory M1 macrophage model, and Fuzheng Huayu Prescription (50, 100, 200 μg/mL) and 10 nmol/L JNK inhibitor SP600125 were incubated respectively. Inflammatory mediator NO production was measured by Griess method. The mRNA expressions of inflammatory cytokines IL-6, TNF-α and iNOS were detected by Real-time RT-PCR. iNOS protein expression and the phosphorylation levels of key proteins in MAPK signaling pathway, namely p-JNK, p-p38 and p-ERK were detected by Western blot. Results Compared with LPS, Fuzheng Huayu Prescription and SP600125 could significantly reduce the overproduction of NO (P<0.01), the overexpression of, 百拇医药(张满 胡旭东 黄恺 陶艳艳 彭渊 刘成海)